Advertisement

Leadership

Board of Directors

The Urology Care Foundation Board of Directors' governance structure is led by the Foundation President and includes AUA member urologists and public directors. The extensive knowledge of this group will be invaluable as the Foundation forges ahead in its efforts to pave a way for advancements in urologic research and patient care.

Harris M. Nagler, MD, FACS

President: Harris M. Nagler, MD, FACS is Professor of Urology at Hofstra Northwell School of Medicine. He previously served as President of Beth Israel Medical Center and Chair of the Sol and Margaret Berger Department of Urology at Beth Israel Medical Center and Professor of Urology at the Icahn School of Medicine at Mount Sinai. At Beth Israel he had also served as the Chief of Graduate Medical Education/Academic Affairs at the Beth Israel; the Program Director of the urology residency-training program, Chief Medical Officer and Physician-in-Chief. Dr Nagler's clinical practice focuses on male infertility, erectile dysfunction and general urology.


Gopal H. Badlani, MD

Secretary: Gopal H. Badlani, MD, is currently professor of urology, vice chair for clinical affairs, and director of the Urogynecology Regenerative Medicine Program at Wake Forest Baptist Medical Center in Winston-Salem, NC. He most recently served as the American Urological Association (AUA) Secretary where he supported the Urology Care Foundation chair, Dr. Memo and the BOD with the Foundation's outreach and development programs. Through his tireless efforts, he helped establish 14 new Research Endowment awards through the Research Scholars Award Program, the flagship research training program of the Foundation.

In 2013, Dr. Badlani was one of three physicians nationwide selected to receive a Physician of the Year Award for Clinical Excellence from Castle Connolly Medical Ltd. The award recognizes physicians who exemplify excellence in clinical medical practice.


David F. Green, MD, FACS

Treasurer: David F. Green, MD, FACS is the chief medical officer at Concord Hospital in Concord, New Hampshire and is a senior partner at Concord Hospital’s Center for Urologic Care. He is also an adjunct associate professor of surgery with the Dartmouth Medical School. Since 2014, he has served as CEO of NH Accountable Care Partners, LLC. Dr. Green has been active in the AUA’s New England Section throughout his career serving as a committee chair and later served as a state representative, secretary and president of the Board of Directors.

On the national level, Dr. Green has served the AUA in various capacities including serving on the Manpower Committee in 1995, serving on the Women in Urology Committee and chairing this between 1996 and 2001. He has served on the Bylaws Committee, the Public Relations Committee and the Audit Committee serving as its Chair in 2012, and was the New England Section Representative to the AUA Board of Directors from 2009 to 2013. From 2012-2013, he served as the Secretary of UROPAC.


Sanford J. Siegel, MD, FACS

At-Large Member: Sanford J. Siegel, MD founded Chesapeake Urology Associates in 1999. He was elected President and CEO of the new Chesapeake Urology Associates in 2006 when Baltimore’s three largest urology practices merged. As President and CEO of Chesapeake Urology, Dr. Siegel has built the group into one of the country’s most prominent urology practices, and the largest in the Mid-Atlantic Region. Dr. Siegel also served on the board of directors for ZERO – The End of Prostate Cancer and currently is a board member of the Park Heights Community Health Alliance (PHCHA).


Lynn Stothers, MD, MHSc

At-Large Member: Mary Ann Lynn Stothers, MD, MHSc is a Professor at the University of British Columbia in the Department of Urologic Sciences. She also serves as Associate Member of the School of Population and Public Health; Associate Member of the Department of Anesthesiology, Pharmacology and Therapeutics; and Associate Member of the Department of Obstetrics and Gynecology.

Dr. Stothers is a principal investigator at the International Collaboration on Repair Discoveries (ICORD), where she has a keen interest in the results and challenges following spinal cord injury. She is committed to her work with hospital foundations and other nonprofits and has been involved in raising funds for urology research and care for more 20 years. She enjoys her time volunteering with the Rick Hansen Institute and helping to raise funds for spinal cord injury research and education.


Larry Lipshultz, MD

Urologist Member: Larry Lipshultz, MD is Professor of Urology and Chief of the Scott Department of Urology's Division of Male Reproductive Medicine and Surgery. Dr. Lipshultz, who holds the Smith Chair in Reproductive Medicine, is a well-known authority on abnormalities of male reproduction, erectile dysfunction, and male hormone production. He also is the AUA's first Research Scholar.

Recognized as a leading expert on men's health, Dr. Lipshultz is a highly respected author and editor, as well as lecturer. His research has been in many journals, books and videos. Dr. Lipshultz instituted a fellowship training program in male reproductive medicine and surgery that has trained more than 80 physicians who are now in practice both in the U.S. and abroad. 


Raju Thomas, MD

Urologist Member: Raju Thomas, MD was named Chair of the Department of Urology at Tulane University Medical Center in New Orleans, Louisiana, effective March 1, 1996. He is also a Professor of Urology and the Residency Program Director for the Department of Urology. Dr. Thomas played a key role in rescuing and rebuilding the Department of Urology at Tulane University following Hurricane Katrina in 2005.


William Koeblitz

Public Member: Jay G. Baitler is currently an operating partner with Atlas Holdings, a private equity firm and diversified group of manufacturing, distribution, service and trading businesses. Prior to Atlas Holdings, Mr. Baitler served as Executive Vice President, Staples Contract Division, from 2004 until his retirement in 2013. During his tenure with Staples, Mr. Baitler oversaw significant growth of the organization, both organic and acquired, and was personally responsible for the integration of Corporate Express, a $4.4 billion acquisition, the largest acquisition in Staples' history. He has been Independent Director of TESSCO Technologies Inc. since 2007 and is also a Director of Iconex.

Mr. Baitler has served on many Boards, including the Board of Managers at Soundview Paper, LLC and the Advisory Boards of Finch Paper, LLC and Twin Rivers Paper Company. Mr. Baitler is a graduate of Union College and currently resides in Palm Beach Gardens, FL.


William Koeblitz

Public Member: Ryan D. Drant specializes in healthcare investments in the medical device, healthcare services, healthcare information technology and specialty pharma sectors, and has been actively investing in healthcare since 1996. He currently serves as the Founder and Managing Director of Questa Capital Management. During his investment career, he has served on 33 boards of directors and has overseen the deployment of $950 million in equity capital. Mr. Drant was named four times to the Forbes Midas List of best venture capital investors.

Prior to founding Questa, Mr. Drant was a General Partner at New Enterprise Associates (NEA), where he joined in 1996, became a General Partner in 2004 and served on the firm's investment committee for 11 years spanning four funds totaling $8.0 billion in total capital. He led the firm's global healthcare investing practice and served as a member of NEA's four-person management committee. Previously, Mr. Drant was with the Health Care Investment Banking Group of Alex. Brown & Sons and Arthur Andersen & Co. Mr. Drant graduated from Stanford University with a BA in Political Science.


Amarpreet Sawhney, PhD

Public Member: Amarpreet Sawhney, PhD is the Chairman of Ocular Therapeutix, Inc., a company focused on solving unmet needs in ophthalmic drug delivery and wound sealing. He is also the Chief Executive Officer and Chairman of Instylla, Inc., a company focused on liquid embolic products for interventional oncology. His entrepreneurism has facilitated the creation of several bio-pharma and medical device companies, as well as the development of such innovative technology solutions as extravascular closure devices, surgical sealants and spacers that enable improved radiotherapy. Dr. Sawhney’s innovations are the subject of more than 120 issued and pending patents in medical devices, methods, and biomaterials. Many of his innovations have been “first of a kind” to be approved by the U.S. Food and Drug Administration.

He has been involved in several charitable causes including ones focused on education, the environment and creating platforms to support other healthcare entrepreneurs. Through his companies and inventions, Dr. Sawhney has touched more than five million patients and created more than 2,000 jobs.

Advertisement